Safety of performing transbronchial lung cryobiopsy on hospitalized patients with interstitial lung disease.
Publication Title
Respiratory medicine
Document Type
Article
Publication Date
7-1-2018
Keywords
Bronchoscopy; Diffuse parenchymal lung disease; Interstitial lung disease; Safety; Transbronchial lung cryobiopsy; Adolescent; Adult; Aged; Aged, 80 and over; Biopsy/adverse effects; Biopsy/methods; Bronchoscopy/adverse effects; Bronchoscopy/methods; Comorbidity; Cryosurgery/adverse effects; Cryosurgery/methods; Female; Hospitalization; Humans; Lung/pathology; Lung Diseases, Interstitial/diagnosis; Lung Diseases, Interstitial/pathology; Male; Middle Aged; Pneumothorax/etiology; Retrospective Studies; Tomography, X-Ray Computed; Young Adult
Abstract
INTRODUCTION: Transbronchial lung cryobiopsy (TBLC) has become a popular option for tissue diagnosis of interstitial lung disease (ILD), however reports vary regarding the safety of this procedure. Herein, we evaluate the safety of transbronchial cryobiopsy in hospitalized patients, comparing adverse events to outpatient procedures.
METHODS AND MEASUREMENTS: This is a single center, retrospective chart review of all TBLC performed for suspected ILD between November 2013 and March 2017. Biopsies were performed by a board certified interventional pulmonologist or interventional pulmonology fellow using a two-scope technique.
RESULTS: One hundred fifty-nine cryobiopsies were performed for the diagnosis of ILD. Rates of adverse events are as follows: pneumothorax 11%, persistent air leak 1.3%, moderate-severe bleeding 3.8%, ICU transfer within 48 h 3.1%, and all cause 30-day mortality 1.9%. No deaths were attributed to the procedure. Comparing adverse events between hospitalized patients and outpatients, rates of pneumothorax were 24% vs 9.9%, persistent air leak 5.9% vs 0.7%, ICU transfer 12% vs 2.1%, and 30-day mortality 5.9% vs 1.4%. However, no differences were statistically significant.
CONCLUSION: Practitioners should recognize that while cryobiopsies are a high-yield, safe, and cost-effective alternative to surgical lung biopsy, not all procedures carry the same risk profiles. Hospitalized patients may have a greater propensity for pneumothorax, persistent air leak, transfer to the ICU, and 30-day mortality.
Specialty/Research Institute
Pulmonary Medicine
